Clinical Trial Update: CTC Pancreatic Adenocarcinoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for circulating tumor cell (CTC) considerations in pancreatic adenocarcinoma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Pancreatic Neoplasms

Snippet

Sponsor: University of Zurich | Conditions: Adenocarcinoma, Circulating Tumor Cells | Phase 4 | Status: COMPLETED